Details of the Drug
General Information of Drug (ID: DMKA25K)
Drug Name |
GWP42006
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Cannabidivarin; Cannabidivarol; CBDV; 24274-48-4; CBD-V; UNII-I198VBV98I; I198VBV98I; Cannabidivarin (CBDV); 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diol; (1'R,2'R)-5'-methyl-2'-(prop-1-en-2-yl)-4-propyl-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol; cannabidivarine; (1R-trans)-2-(3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-propyl-1,3-benzenediol; SCHEMBL2759238; CHEMBL2387742; DTXSID801019159; ZINC5844413; BDBM50532215; AKOS030242161; DB14050; SB18950; 1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-propyl-, (1R-trans)-; C20217; Cannabidivarin (CBDV) 100 microg/mL in Methanol; Cannabidivarin (CBDV) 1000 microg/mL in Methanol
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||